| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052309471 |
| P356 | DOI | 10.1038/KI.2012.234 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ki.2012.234 |
| P932 | PMC publication ID | 3472108 |
| P698 | PubMed publication ID | 22718189 |
| P5875 | ResearchGate publication ID | 227709867 |
| P2093 | author name string | E Jennifer Weil | |
| Robert G Nelson | |||
| Clinton C Mason | |||
| Bryan D Myers | |||
| Kristina Blouch | |||
| Kevin V Lemley | |||
| Berne Yee | |||
| Lois I Jones | |||
| Meghan Richardson | |||
| Tracy Lovato | |||
| P2860 | cites work | VEGF inhibition and renal thrombotic microangiopathy | Q24632792 |
| Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier | Q24644639 | ||
| Evolution of incipient nephropathy in type 2 diabetes mellitus | Q28145309 | ||
| Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. | Q33271012 | ||
| High glucose causes dysfunction of the human glomerular endothelial glycocalyx | Q34501882 | ||
| Structural-functional relationships in diabetic nephropathy | Q34616152 | ||
| Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases | Q34835409 | ||
| Podocyte detachment in type 2 diabetic nephropathy | Q35063584 | ||
| Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death | Q35267185 | ||
| Effects of aging on glomerular function and number in living kidney donors | Q35964514 | ||
| The podocyte's response to injury: role in proteinuria and glomerulosclerosis | Q36474870 | ||
| Proteinuria in diabetic kidney disease: a mechanistic viewpoint | Q37140616 | ||
| Podocyte loss and progressive glomerular injury in type II diabetes | Q37362675 | ||
| Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians | Q39622035 | ||
| Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria | Q40790842 | ||
| Determination of membrane thickness distribution from orthogonal intercepts | Q41456217 | ||
| Regression of microalbuminuria in type 1 diabetes | Q44467189 | ||
| Extent and course of glomerular injury in human membranous glomerulopathy | Q46045287 | ||
| The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy | Q46055262 | ||
| Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy | Q46870214 | ||
| Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. | Q46917089 | ||
| Large glomerular size in Pima Indians: lack of change with diabetic nephropathy | Q47408978 | ||
| Nature of glomerular dysfunction in pre-eclampsia. | Q52234872 | ||
| Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. | Q53288801 | ||
| Structural determinants of glomerular hydraulic permeability. | Q54217558 | ||
| Nonalbuminuric renal insufficiency in type 2 diabetes. | Q55037977 | ||
| Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. | Q60748236 | ||
| How Many Glomerular Profiles Must Be Measured to Obtain Reliable Estimates of Mean Glomerular Areas in Human Renal Biopsies? | Q67191506 | ||
| Glomerular podocyte degeneration in human renal disease: an ultrastructural study | Q67588196 | ||
| Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia | Q71324990 | ||
| Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus | Q73128414 | ||
| Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes | Q73188441 | ||
| Glomerular cell number in normal subjects and in type 1 diabetic patients | Q73942888 | ||
| Course of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus | Q73960813 | ||
| Urinary excretion of podocytes in patients with diabetic nephropathy | Q74291207 | ||
| Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients | Q76393308 | ||
| Determination of creatinine by means of automatic chemical analysis | Q78815634 | ||
| Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy | Q80400727 | ||
| Hypertrophy and loss of podocytes in diabetic nephropathy | Q84563310 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| kidney disease | Q1054718 | ||
| P304 | page(s) | 1010-1017 | |
| P577 | publication date | 2012-06-20 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy | |
| P478 | volume | 82 |
| Q64235493 | A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy |
| Q60919748 | A mitochondrial-targeted peptide ameliorated podocyte apoptosis through a HOCl-alb-enhanced and mitochondria-dependent signalling pathway in diabetic rats and in vitro |
| Q45972129 | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q38289926 | Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1. |
| Q36921163 | Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice |
| Q50475761 | Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes. |
| Q38601433 | Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study |
| Q43410167 | An inducible mouse model of podocin-mutation-related nephrotic syndrome |
| Q90495501 | Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes |
| Q42418585 | Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice |
| Q92620817 | Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats |
| Q34551722 | Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs |
| Q92840272 | CXCR3 knockdown protects against high glucose-induced podocyte apoptosis and inflammatory cytokine production at the onset of diabetic nephropathy |
| Q37018458 | Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. |
| Q42035564 | Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice. |
| Q40322521 | Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications. |
| Q38332511 | Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes |
| Q38781550 | Developing Treatments for Chronic Kidney Disease in the 21st Century |
| Q38709338 | Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies |
| Q34387952 | Diabetic nephropathy - complications and treatment |
| Q37110513 | Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes? |
| Q51631984 | Dynamin Autonomously Regulates Podocyte Focal Adhesion Maturation. |
| Q36719266 | Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity |
| Q37110523 | Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. |
| Q90567931 | Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease |
| Q35082779 | Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. |
| Q90871287 | Endothelium structure and function in kidney health and disease |
| Q37014982 | From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy |
| Q36531604 | Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro |
| Q46453178 | Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility |
| Q99350177 | Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes |
| Q35086477 | Glomerular endothelial cell injury and cross talk in diabetic kidney disease |
| Q41659776 | Glomerular parietal epithelial cell activation induces collagen secretion and thickening of Bowman's capsule in diabetes |
| Q38596700 | Glucose Homeostasis and Cardiovascular Alterations in Diabetes |
| Q39508501 | Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro |
| Q27343126 | Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. |
| Q89578732 | IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target |
| Q64994129 | Increased levels of serum pigment epithelium-derived factor aggravate proteinuria via induction of podocyte actin rearrangement. |
| Q46159289 | Is endothelial dysfunction more deleterious than podocyte injury in diabetic nephropathy? |
| Q92282381 | LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis |
| Q50047987 | Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial‑mesenchymal transition in diabetic rats. |
| Q92136302 | Long-term case study of a Wuzhishan miniature pig with diabetes |
| Q35303995 | Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell culture |
| Q48530981 | Mechanism of Mer receptor tyrosine kinase inhibition of glomerular endothelial cell inflammation. |
| Q28083976 | Membrane flexibility, free fatty acids, and the onset of vascular and neurological lesions in type 2 diabetes |
| Q51726683 | Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats. |
| Q55709365 | Modified scanning electron microscopy reveals pathological crosstalk between endothelial cells and podocytes in a murine model of membranoproliferative glomerulonephritis. |
| Q37590946 | New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy |
| Q47395215 | Novel avenues for drug discovery in diabetic kidney disease |
| Q38219572 | Novel urinary biomarkers in early diabetic kidney disease |
| Q37022134 | PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria |
| Q54286862 | PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes. |
| Q37219039 | Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease |
| Q57916044 | Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators |
| Q33821237 | Podocytes, signaling pathways, and vascular factors in diabetic kidney disease |
| Q37340690 | Podocytes: the Weakest Link in Diabetic Kidney Disease? |
| Q64915718 | Prompt apoptotic response to high glucose in SGLT-expressing renal cells. |
| Q89964386 | Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes |
| Q87792034 | Putting the glomerulus back together: per aspera ad astra ("a rough road leads to the stars") |
| Q26740433 | Recent Progress in Stem Cell Therapy for Diabetic Nephropathy |
| Q38262105 | Renin-angiotensin system within the diabetic podocyte |
| Q37587328 | Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy |
| Q64265044 | Resveratrol Reduces Oxidative Stress and Apoptosis in Podocytes via Sir2-Related Enzymes, Sirtuins1 (SIRT1)/Peroxisome Proliferator-Activated Receptor γ Co-Activator 1α (PGC-1α) Axis |
| Q35543167 | Review series: The cell biology of renal filtration |
| Q92756435 | Role of Vitamin D Status in Diabetic Patients with Renal Disease |
| Q92163781 | SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors |
| Q52646173 | SRGAP2a: A New Player That Modulates Podocyte Cytoskeleton and Injury in Diabetes. |
| Q89064919 | Shift in Focus-To Explore the Role of the Endothelium in Kidney Disease |
| Q37280851 | Short-term changes after a weight reduction intervention in advanced diabetic nephropathy |
| Q33741426 | Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus. |
| Q36543068 | Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes |
| Q37325431 | TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis |
| Q38109847 | Temporal profile of diabetic nephropathy pathologic changes |
| Q59813465 | The Evolving Importance of Insulin Signaling in Podocyte Health and Disease |
| Q90638915 | The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development |
| Q51630441 | The Podocyte Count Detected by an Improved Immunocytochemical Method has Higher Diagnostic Efficiency than Enzyme-Linked Immunosorbent Assay and Serum Cystatin C to Evaluate the Early Stage Damage of Glomerular. |
| Q87018918 | The endothelium as part of the integrative glomerular barrier complex |
| Q38195528 | The endothelium in diabetic nephropathy |
| Q87440684 | The glomerular endothelium emerges as a key player in diabetic nephropathy |
| Q48649007 | The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions. |
| Q36299942 | The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy |
| Q93128835 | The protective effect and mechanism of catalpol on high glucose-induced podocyte injury |
| Q35239936 | The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy |
| Q38087656 | The renal endothelium in diabetic nephropathy |
| Q51328717 | Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study. |
| Q37089424 | Transforming growth factor-beta and the glomerular filtration barrier |
| Q90726270 | Transplanted senescent renal scattered tubular-like cells induce injury in the mouse kidney |
| Q36723318 | Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes |
| Q89837558 | Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes |
| Q35816851 | Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients |
| Q27342809 | Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy |
| Q39010377 | Vascular endothelium in diabetes |
| Q46765226 | White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes |
| Q57491629 | Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression |
| Q90167846 | mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans |
Search more.